FDA Adverse Event Injury Summary report: N

ASR ACETABULAR CUPS 56

MDR report key: 3232938 · Received July 18, 2013

Report

Report Number
1818910-2013-21512
Event Type
Injury
Date Received
July 18, 2013
Date of Event
July 16, 2013
Report Date
October 15, 2013
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KWA
PMA / PMN Number
PK040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

**UPDATE**(B)(4) 2013 - LITIGATION PAPERS RECEIVED. LITIGATION ALLEGES TROCHANTERIC FLUID, IMPLANT FAILURE, METALLOSIS AND PAIN. THERE IS NO NEW ADDITIONAL INFORMATION THAT WOULD AFFECT THE INVESTIGATION. **UPDATE** - MEDICAL RECORDS RECEIVED (B)(4) 2013. REVISION OPERATIVE REPORT INDICATES THE FOLLOWING: ELEVATED COBALT CHROME LEVELS; STIFFNESS IN THE HIP; SOME PAIN; METALLOSIS; LARGE PSEUDOCAPSULE WITH FLUID; FAIR AMOUNT OF SCARRING. WITH INFORMATION PROVIDED, INVOICE WAS LOCATED. LOT NUMBERS ARE BEING REPORTED. THE INFORMATION RECEIVED DOES NOT CHANGE THE MDR DECISION.

Description of Event or Problem · 1

PATIENT UNDERWENT REVISION PROCEDURE OF RIGHT HIP DUE TO PSEUDOCAPSULE, SCAR TISSUE, ELEVATED ION LEVELS, AND BLACKENED TISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
336330 ASR ACETABULAR CUPS 56 ACETABULAR CUP KWA DEPUY INTL., LTD. - 8010379 2346792

Patients

Seq Age Sex Outcome Treatment
1 56 YR Required Intervention